14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.25 $5.20 Thursday, 25th Apr 2024 AVXL stock ended at $3.39. This is 0.587% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.62% from a day low at $3.25 to a day high of $3.47.
90 days $3.25 $6.90
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Dec 07, 2020 $4.90 $4.97 $4.68 $4.82 654 582
Dec 04, 2020 $4.90 $4.99 $4.53 $4.87 1 456 324
Dec 03, 2020 $5.39 $5.48 $4.91 $4.96 1 142 765
Dec 02, 2020 $5.22 $5.48 $5.15 $5.44 661 877
Dec 01, 2020 $5.33 $5.54 $5.22 $5.24 829 029
Nov 30, 2020 $5.43 $5.50 $5.19 $5.33 781 809
Nov 27, 2020 $5.19 $5.40 $5.18 $5.37 550 720
Nov 25, 2020 $4.95 $5.27 $4.92 $5.20 548 299
Nov 24, 2020 $5.15 $5.15 $4.90 $4.95 934 973
Nov 23, 2020 $5.15 $5.23 $5.05 $5.15 555 477
Nov 20, 2020 $5.03 $5.20 $4.96 $5.17 576 492
Nov 19, 2020 $5.17 $5.18 $4.91 $5.06 603 293
Nov 18, 2020 $5.23 $5.36 $5.13 $5.17 560 806
Nov 17, 2020 $5.18 $5.37 $5.13 $5.22 623 847
Nov 16, 2020 $5.38 $5.41 $4.98 $5.20 1 372 853
Nov 13, 2020 $5.37 $5.43 $5.21 $5.38 644 899
Nov 12, 2020 $5.24 $5.45 $5.10 $5.36 740 006
Nov 11, 2020 $5.43 $5.46 $5.21 $5.25 1 052 360
Nov 10, 2020 $5.12 $5.42 $4.80 $5.42 2 006 711
Nov 09, 2020 $5.66 $5.74 $4.89 $4.91 2 808 532
Nov 06, 2020 $7.56 $7.69 $4.86 $4.91 7 676 792
Nov 05, 2020 $6.45 $7.66 $6.37 $7.58 2 796 998
Nov 04, 2020 $6.09 $6.65 $6.05 $6.34 1 747 866
Nov 03, 2020 $5.74 $6.10 $5.62 $6.07 1 074 362
Nov 02, 2020 $5.97 $5.99 $5.59 $5.71 828 369
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT